211
Views
20
CrossRef citations to date
0
Altmetric
Original Research

Pharmacovigilance and adverse drug reaction reporting: a perspective of community pharmacists and pharmacy technicians in Sana’a, Yemen

, , , , , , & show all
Pages 1175-1181 | Published online: 07 Sep 2017

References

  • World Health OrganizationThe Importance of Pharmacovigilance – Safety Monitoring of Medicinal ProductsWHO Collaborating Centre for International Drug MonitoringGeneva, Switzerland2002
  • AbdulRazzaqHAAzizNASyed SulaimanSAHassanYKassabYWIsmailOAdverse drug reactions of statin based on patients’ self reportsJ Pharm Res201252864868
  • World Health OrganizationThe Safety of Medicines in Public Health Programmes: Pharmacovigilance, an Essential Tool Available from: http://www.who.int/medicines/areas/quality_safety/safety_efficacy/Pharmacovigilance_B.pdfAccessed April 28, 2017
  • RosliRDaliAFAzizNAMingLCMananMMReported adverse drug reactions in infants: a nationwide analysis in MalaysiaFront Pharmacol201783028239351
  • RosliRMingLCAbd AzizNMananMMA retrospective analysis of spontaneous adverse drug reactions reports relating to paediatric patientsPLoS One2016116e015538527249414
  • AminMNKhanTMDewanSMIslamMSMoghalMRMingLCCross-sectional study exploring barriers to adverse drug reactions reporting in community pharmacy settings in Dhaka, BangladeshBMJ Open201668e010912
  • HadiMANeohCFZinRMElrggalMECheemaEPharmacovigilance: pharmacists’ perspective on spontaneous adverse drug reaction reportingIntegr Pharm Res Pra201769198
  • HadiMAHelwaniRLongCMFacilitators and barriers towards adverse drug reaction reporting: perspective of Malaysian hospital pharmacistsJ Pharm Health Serv Res201343155158
  • HadiMAMingLCImpact of pharmacist recruitment on ADR reporting: Malaysian experienceSouth Med Rev20114210210323093890
  • Al-WorafiYMPharmacy practice and its challenges in YemenAustralas Med J201471172324567762
  • Al-WorafiYMThe challenges of pharmacy education in YemenAm J Pharm Educ201478814625386011
  • Al-WorafiYMComment on: “Pharmacovigilance in the Middle East”Drug Saf201437865165224985531
  • Lopez-GonzalezEHerdeiroMTFigueirasADeterminants of under-reporting of adverse drug reactions: a systematic reviewDrug Saf2009321193119132802
  • VessalGMardaniZMollaiMKnowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in IranPharm World Sci200931218318719116770
  • Ministry of Public Health and PopulationMinistry of Public Health and Population. Annual Statistical Health Report 2011 Available from: http://www.mophp-ye.org/arabic/docs/Report2011.pdfAccessed April 28, 2017 Arabic
  • World Health OrganizationPharmacovigilance: Ensuring the Safe Use of Medicines – WHO Policy Perspectives on Medicines, No. 009, October 2004 Available from: http://apps.who.int/medicinedocs/en/d/Js6164e/Accessed April 28, 2017
  • GreenCFMottramDRRowePHPirmohamedMAttitudes and knowledge of hospital pharmacists to adverse drug reaction reportingBr J Clin Pharmacol2001511818611167664
  • MesKde Jong-van den BergLTVan GrootheestACAttitudes of community pharmacists in the Netherlands towards adverse drug reaction reportingInt J Pharm Pract2002104267272
  • MahmoudMAAlswaidaYAlshammariTCommunity pharmacists’ knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi ArabiaSaudi Pharm J201422541141825473329
  • KhanTMCommunity pharmacists’ knowledge and perceptions about adverse drug reactions and barriers towards their reporting in Eastern region, Alahsa, Saudi ArabiaTher Adv Drug Saf201342455125083250
  • Al-WorafiYMPharmacy education in YemenAm J Pharm Educ20137736523610483
  • BawazirSAAttitude of community pharmacists in Saudi Arabia towards adverse drug reaction reportingSaudi Pharm J20061417583
  • SuyaghMFarahDAbu FarhaRPharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting processSaudi Pharm J201523214715325972734
  • JoseJJimmyBAl-GhailaniASAl MajaliMAA cross sectional pilot study on assessing the knowledge, attitude and behavior of community pharmacists to adverse drug reaction related aspects in the Sultanate of OmanSaudi Pharm J201422216316924648829